AA
RGNX icon

ALPS Advisors’s Regenxbio RGNX Stock Holding History

ALPS Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42,012
Closed -$352K – 1209
2026
Q1 		$352K Buy
42,012
+444
+1% +$4.67K ﹤0.01% 963
2025
Q4 		$599K Buy
41,568
+16,851
+68% +$210K ﹤0.01% 680
2025
Q3 		$239K Sell
24,717
-2,328
-9% -$20.6K ﹤0.01% 1004
2025
Q2 		$222K Buy
+27,045
New +$226K ﹤0.01% 1001
2023
Q2 		– Sell
-28,632
Closed -$541K – 1026
2023
Q1 		$541K Sell
28,632
-713
-2% -$15.8K ﹤0.01% 584
2022
Q4 		$666K Buy
29,345
+5,713
+24% +$129K 0.01% 540
2022
Q3 		$625K Sell
23,632
-1,956
-8% -$58K 0.01% 557
2022
Q2 		$632K Sell
25,588
-18,550
-42% -$463K 0.01% 543
2022
Q1 		$1.47M Sell
44,138
-5,353
-11% -$149K 0.02% 276
2021
Q4 		$1.62M Sell
49,491
-2,721
-5% -$92.7K 0.02% 308
2021
Q3 		$2.19M Sell
52,212
-3,772
-7% -$136K 0.02% 302
2021
Q2 		$2.17M Sell
55,984
-20,904
-27% -$748K 0.02% 308
2021
Q1 		$2.62M Buy
76,888
+9,407
+14% +$401K 0.03% 233
2020
Q4 		$3.06M Buy
+67,481
New +$2.36M 0.03% 213
2019
Q3 		– Sell
-6,657
Closed -$342K – 965
2019
Q2 		$342K Sell
6,657
-352
-5% -$17.6K ﹤0.01% 807
2019
Q1 		$402K Buy
7,009
+605
+9% +$30K ﹤0.01% 695
2018
Q4 		$269K Sell
6,404
-266
-4% -$15.6K ﹤0.01% 825
2018
Q3 		$504K Buy
+6,670
New +$481K ﹤0.01% 596

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

ALPS Advisors's RGNX Position: Q2 2026 in Review

ALPS Advisors sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 42,012 shares — an estimated $352K sold.

ALPS Advisors first reported a position in RGNX in Q3 2018 and held it in 18 quarters. The position peaked at $3.06M in Q4 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • ALPS Advisors reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • ALPS Advisors sold 42,012 Regenxbio shares in Q2 2026, an estimated $352K.
  • ALPS Advisors first reported a position in Regenxbio in Q3 2018 and held it in 18 quarters.
  • ALPS Advisors's Regenxbio position peaked at $3.06M in Q4 2020.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.